STOCK TITAN

Juniper group reports 1,864,449 AORT shares; sold 233,715 for $9.54M

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Juniper Investment-affiliated reporting persons amended their Schedule 13D to report a decrease in their beneficial ownership of Artivion, Inc. common stock to 1,864,449 shares, representing approximately 4.0% of outstanding shares as of the record date. Between June 17, 2025 and August 11, 2025 Juniper Targeted Opportunities, L.P. sold 233,715 shares in the open market for an aggregate sale price of approximately $9,540,725, which includes brokerage commissions. Percentages are calculated using 47,183,656 shares outstanding as of August 1, 2025.

The filing breaks out ownership by entity: Juniper Fund holds 1,473,656 shares (about 3.1%), Juniper Targeted Opportunities holds 377,308 shares (about 0.8%), and Juniper Multi-Strategy holds 13,485 shares (about 0.0%). Juniper Investment Company and the named managing members may be deemed to beneficially own the aggregate shares but disclaim ownership for other purposes. The amendment references a Joint Filing Agreement and a schedule of transactions as exhibits.

Positive

  • Transparent disclosure: The Reporting Persons filed an amendment to disclose the sale and updated beneficial ownership figures.
  • Current ownership reported: Aggregate beneficial ownership of 1,864,449 shares, representing approximately 4.0% of outstanding shares as of the record date.
  • Transaction details provided: The amendment specifies the number of shares sold (233,715) and the aggregate sale proceeds (approximately $9,540,725 including commissions).

Negative

  • Reduction in stake: Reporting Persons sold shares, resulting in a decreased beneficial ownership percentage.
  • Concentrated disposals: 233,715 shares were sold in the open market between June 17, 2025 and August 11, 2025 for approximately $9,540,725, reducing the group’s position.

Insights

TL;DR: Juniper disclosed an open-market sale reducing its Artivion stake to 4.0% after selling 233,715 shares for about $9.54M.

The amendment reports a non-controlling but material passive position of 1,864,449 shares, calculated on 47,183,656 shares outstanding as of August 1, 2025. The sale generated approximately $9.54 million including commissions and occurred in the open market between June 17, 2025 and August 11, 2025. The filing clarifies which affiliated entities hold voting and dispositive power and identifies the named managing members who signed the amendment.

TL;DR: The Schedule 13D/A updates ownership, voting and dispositive allocations among related Juniper entities and attaches required exhibits for transparency.

The filing details entity-level holdings and explicitly states which entities have sole voting and dispositive power over their respective shares while noting that Juniper Investment Company and the managing members may be deemed to beneficially own the aggregate shares but disclaim ownership for other purposes. Exhibits include a Joint Filing Agreement and a schedule of transactions, ensuring coordinated disclosure by the group.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Juniper Targeted Opportunity Fund, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper HF Investors II, LLC
Date:08/11/2025
Juniper HF Investors II, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Juniper Targeted Opportunities, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper Targeted Opportunity Investors, LLC
Date:08/11/2025
Juniper Targeted Opportunity Investors, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Juniper Multi-Strategy Fund, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper HF Investors
Date:08/11/2025
Juniper HF Investors, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Juniper Investment Company, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Alexis P. Michas
Signature:/s/ Alexis P. Michas
Name/Title:Alexis P. Michas
Date:08/11/2025
John A. Bartholdson
Signature:/s/ John A. Bartholdson
Name/Title:John P. Bartholdson
Date:08/11/2025

FAQ

What stake does Juniper report in Artivion (AORT)?

The Reporting Persons collectively beneficially own 1,864,449 shares, representing approximately 4.0% of Artivion's outstanding common stock based on 47,183,656 shares as of the August 1, 2025 record date.

How many shares did Juniper sell and for how much?

Juniper Targeted Opportunities, L.P. sold 233,715 shares in the open market for an aggregate sale price of approximately $9,540,725, including brokerage commissions, between June 17, 2025 and August 11, 2025.

Which Juniper entities hold Artivion shares and what are their amounts?

Juniper Targeted Opportunity Fund, L.P. holds 1,473,656 shares (about 3.1%), Juniper Targeted Opportunities, L.P. holds 377,308 shares (about 0.8%), and Juniper Multi-Strategy Fund, L.P. holds 13,485 shares (about 0.0%).

Who are the reporting persons and signatories on the filing?

The filing is by multiple Juniper entities and individuals, including Juniper Investment Company, LLC and managing members Alexis P. Michas and John A. Bartholdson. Contact details for notices include Juniper Investment Company, LLC at 555 Madison Avenue, 24th Floor, New York, NY 10022 and phone (212) 339-8500.

What exhibits were filed with the Schedule 13D/A?

Exhibit B: Joint Filing Agreement (incorporated by reference) and Exhibit C: Schedule of Transactions.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.19B
43.29M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW